Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitric oxide and angiogenesis.

M Ziche1, L Morbidelli

  • 1Institute of Pharmacological Sciences, University of Siena, Italy. ziche@unisi.it

Journal of Neuro-Oncology
|March 14, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review.

Neoplasma·2019
Same author

ALDH2 Activity Reduces Mitochondrial Oxygen Reserve Capacity in Endothelial Cells and Induces Senescence Properties.

Oxidative medicine and cellular longevity·2018
Same author

Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2 S availability.

British journal of pharmacology·2015
Same author

EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity.

Oncogene·2011
Same author

A nanoscale fluorocarbon coating on PET surfaces improves the adhesion and growth of cultured coronary endothelial cells.

Nanotechnology·2011
Same author

Angiogenic phenotype induced by basic fibroblast growth factor transfection in brain microvascular endothelial cells.

International journal of oncology·2011

Nitric oxide (NO) is crucial for new blood vessel growth (angiogenesis) and is linked to vasodilation. Targeting the NO pathway offers potential therapeutic strategies for both promoting and inhibiting angiogenesis.

Area of Science:

  • Vascular Biology
  • Molecular Medicine
  • Oncology

Background:

  • Angiogenesis, the formation of new blood vessels, is a complex biological process involving cell interactions, proliferation, and migration.
  • A link between vasodilation and angiogenesis is suggested by observations of vasodilation during angiogenesis and the vasodilating properties of angiogenesis effectors.
  • Nitric oxide (NO), the primary mediator of vasodilation, is implicated in both physiological and pathological angiogenesis.

Purpose of the Study:

  • To explore the multifaceted role of nitric oxide (NO) in angiogenesis.
  • To investigate the molecular mechanisms by which NO influences endothelial cell behavior and blood vessel formation.
  • To evaluate the therapeutic potential of targeting the NO pathway in angiogenesis-related diseases and cancer.

Main Methods:

Related Experiment Videos

  • Review of existing scientific literature and experimental data on nitric oxide, angiogenesis, and endothelial cell function.
  • Analysis of the molecular signaling pathways involved in NO-mediated angiogenesis, including ec-NOS activation, cGMP elevation, MAPK signaling, and FGF-2 expression.
  • Examination of the correlation between nitric oxide synthase (NOS) activity, tumor progression, and edema formation in experimental and human tumors.

Main Results:

  • Nitric oxide (NO) acts as both an 'actor' and 'director' in angiogenesis, promoting endothelial cell survival, growth, and differentiation.
  • NO signaling involves endothelial-constitutive NO synthase (ec-NOS) activation, cyclic GMP (cGMP) elevation, mitogen-activated kinase (MAPK) activation, and fibroblast growth factor-2 (FGF-2) expression.
  • Elevated NOS activity is correlated with tumor progression and brain tumor expansion; NOS inhibition reduces tumor-related edema.

Conclusions:

  • The nitric oxide pathway plays a significant role in regulating angiogenesis in both physiological and pathological conditions.
  • Targeting the NO pathway presents a promising therapeutic avenue for managing angiogenesis-related disorders, including cancer.
  • NOS inhibitors may be beneficial in reducing edema, blocking tumor angiogenesis, and enhancing the delivery of anti-cancer drugs.